Taken together, our data indicated that PLGL was able to upregulate CPT11 drug activity and destabilize clnE, which appeared activating Chk1 mediated checkpoint for eliminating colon cancer cells. This evidence concerns the gene CHEK1 and malignant colon neoplasm.